UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Jason Somer Transition Agreement
As previously announced in the Current Report on Form 8-K filed by Inogen, Inc. (the “Company”), dated July 2, 2024, the Company and Jason Somer, Executive Vice President, General Counsel and Secretary of the Company, mutually determined that Mr. Somer would separate from the Company on July 19, 2024. Mr. Somer’s role as an officer and employee of the Company ended effective July 19, 2024 (the “Separation Date”). In connection with the separation of Mr. Somer’s employment with the Company, on July 26, 2024, Mr. Somer and the Company entered into a transition agreement and release related to the termination of Mr. Somer’s employment with the Company (the “Transition Agreement”).
The Transition Agreement provides that, subject to (a) Mr. Somer’s execution of the Transition Agreement, (b) the Transition Agreement becoming effective, and (c) Mr. Somer’s continued compliance with the terms of the Transition Agreement, the Company will provide Mr. Somer with the severance benefits consistent with Mr. Somer’s Employment and Severance Agreement with the Company, dated July 12, 2021.
The summary of the Transition Agreement set forth above does not purport to be complete and is qualified in its entirety by reference to the full text of the Transition Agreement, which is attached to this Current Report on Form 8-K as Exhibit 10.1 and incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit |
|
Description |
10.1 |
|
Transition Agreement and Release by and between the Company and Jason M. Somer, dated July 26, 2024. |
104 |
|
The cover page of this Current Report on Form 8-K, formatted in inline XBRL. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
INOGEN, INC. |
|
|
|
|
Date: |
July 31, 2024 |
By: |
/s/ Michael Bourque |
|
|
|
Michael Bourque |